Drug Shortage Report for AMIKACIN SULFATE INJECTION

Last updated on 2021-04-26 History
Report ID 129150
Drug Identification Number 02486717
Brand name AMIKACIN SULFATE INJECTION
Common or Proper name Amikacin Sulfate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) AMIKACIN
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 2mL vial / fiole
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-10-23
Estimated end date 2021-04-06
Actual end date 2021-04-12
Shortage status Resolved
Updated date 2021-04-26
Company comments Demand on the market.
Health Canada comments
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-26 French Compare
v5 2021-04-26 English Compare
v4 2021-02-25 French Compare
v3 2021-02-25 English Compare
v2 2020-11-30 French Compare
v1 2020-11-30 English Compare